Greg Carr

AstraZeneca
CMC Regulatory Affairs Senior Director and Group Manager
Greg Carr has worked in the pharmaceutical industry for over 20 years with experience in R&D, quality assurance, pharmaceutical technology, manufacturing, and supply chain. After graduating with a master’s degree in chemistry, Greg worked in discovery sciences for 10 years before moving into CMC regulatory roles, where he has worked with a variety of products and dosage forms over the product life cycle. He is Senior Director and Group Manager in CMC Regulatory Affairs at AstraZeneca.

Related Articles

A New Regulatory Approach to Drive Sustainable Medicines
Features
A New Regulatory Approach to Drive Sustainable Medicines

To enable changes across the pharmaceutical industry, sustainability should be included alongside quality, efficacy, and safety when assessing medicines. This article reviews two case studies that cover sustainable pack types and extension of shelf life. With the drive to manage unmet medical need through acceleration of drug development programs, postapproval sustainability variations will...